{
    "Trade/Device Name(s)": [
        "Simplexa Bordetella Direct MOL2750",
        "Simplexa Bordetella Positive Control Pack MOL2760",
        "Simplexa Bordetella Direct",
        "Simplexa Bordetella Positive Control Pack"
    ],
    "Submitter Information": "DiaSorin Molecular LLC",
    "510(k) Number": "K173498",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163626"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZZ"
    ],
    "Summary Letter Date": "November 16, 2017",
    "Summary Letter Received Date": "November 17, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Bordetella pertussis",
        "Bordetella parapertussis"
    ],
    "Specimen Type(s)": [
        "Frozen nasopharyngeal (NPS) specimens",
        "Nasopharyngeal swabs"
    ],
    "Specimen Container(s)": [
        "Remel M4",
        "Remel M4RT",
        "Remel M5",
        "Remel M6",
        "UTM",
        "VTM",
        "Liquid Amies (ESwab)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON MDX instrument",
        "LIAISON MDX Studio Software"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "PCR-based detection",
        "Multiplex fluorescent probe detection",
        "Qualitative nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Reagent",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Simplexa Bordetella Direct qualitative real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens on the LIAISON MDX instrument",
    "Indications for Use Summary": "Qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids from frozen nasopharyngeal specimens from patients with signs and symptoms of Bordetella infection of the respiratory tract, used as an aid in diagnosis in conjunction with other clinical and epidemiological information",
    "fda_folder": "Microbiology"
}